Scholarlink

Background <p>Gestational diabetes mellitus (GDM) prevalence (9–15%) is similar in Ghana and Switzerland, despite differences in sociodemographic characteristics, lifestyle, and healthcare systems. Contrary to Switzerland, data on the metabolic and mental health outcomes of women with GDM in Ghana is lacking. We compared the metabolic, mental health, and perinatal outcomes of GDM during pregnancy in Ghana and Switzerland.</p> Methods <p>This prospective observational study included 170 women with GDM from two cohorts (<i>n</i> = 88 in Switzerland, <i>n</i> = 82 in Ghana) who were followed-up until delivery. Primary outcomes were metabolic [HbA1c, gestational weight gain (GWG)], well-being (WHO-5), and depression symptoms (EPDS) during pregnancy. Secondary outcomes were obstetric and neonatal outcomes. Differences in metabolic, mental health and perinatal outcomes were tested using ANOVA, Chi-square test or ANCOVA when appropriate. For the perinatal outcomes, we adjusted for metabolic confounders.</p> Results <p>Compared to the Swiss cohort (SC), the Ghana cohort (GC) had a higher pre-pregnancy weight (79.8 ± 18.0 vs. 71.8 ± 15.3&#xa0;kg, <i>p</i> = 0.003) and BMI (30.8 ± 6.6 vs. 26.5 ± 4.9&#xa0;kg/m<sup>2</sup>, <i>p</i> &lt; 0.001), lower total GWG (6.2 ± 5.4 vs. 11.3 ± 5.8&#xa0;kg, <i>p</i> &lt; 0.001), but similar BMI-based excessive weight gain, higher fasting glucose (7.1 ± 2.4 vs. 5.1 ± 0.7 mmol/l) and HbA1c at GDM diagnosis (5.6 ± 1.0 vs. 5.3 ± 0.3%; both <i>p</i> ≤ 0.019), higher prevalence of previously undiagnosed pre-existing diabetes before 15-weeks gestational age (35.4% vs. 9.4%) and of metformin-treated women (84% vs. 1.1%, both <i>p</i> ≤ 0.001). The GC had higher well-being scores (74.4 ± 17.6 vs. 59.8 ± 18.3, <i>p</i> &lt; 0.001), but similar symptoms of depression scores. In the GC, LGA (30% vs. 17%), and NICU hospitalizations (42% vs. 15%) were higher (all <i>p</i> ≤ 0.044) independent of HbA1c and pre-pregnancy BMI.</p> Conclusion <p>Women in the GC had worse metabolic outcomes but improved mental health during pregnancy. In this context, LGA and neonatal hospitalisations were higher, independent of HbA1c and pre-pregnancy BMI. Our results suggest the need for specialized GDM clinics in Ghana to improve metabolic and perinatal outcomes in women with GDM.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Comparative differences in metabolic, mental health and perinatal outcomes of women with gestational diabetes in Ghana and Switzerland: the G-MUM study

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年4月15日

查看全文
  • Dan Yedu Quansah,
  • Kelvin Yeboah,
  • Floriane Schweitzer,
  • Sandra Yedu Quansah,
  • Evans Kofi Agbeno,
  • Antje Horsch,
  • Katrien Benhalima,
  • A. Kofi Amegah,
  • Jardena J. Puder

摘要

Background

Gestational diabetes mellitus (GDM) prevalence (9–15%) is similar in Ghana and Switzerland, despite differences in sociodemographic characteristics, lifestyle, and healthcare systems. Contrary to Switzerland, data on the metabolic and mental health outcomes of women with GDM in Ghana is lacking. We compared the metabolic, mental health, and perinatal outcomes of GDM during pregnancy in Ghana and Switzerland.

Methods

This prospective observational study included 170 women with GDM from two cohorts (n = 88 in Switzerland, n = 82 in Ghana) who were followed-up until delivery. Primary outcomes were metabolic [HbA1c, gestational weight gain (GWG)], well-being (WHO-5), and depression symptoms (EPDS) during pregnancy. Secondary outcomes were obstetric and neonatal outcomes. Differences in metabolic, mental health and perinatal outcomes were tested using ANOVA, Chi-square test or ANCOVA when appropriate. For the perinatal outcomes, we adjusted for metabolic confounders.

Results

Compared to the Swiss cohort (SC), the Ghana cohort (GC) had a higher pre-pregnancy weight (79.8 ± 18.0 vs. 71.8 ± 15.3 kg, p = 0.003) and BMI (30.8 ± 6.6 vs. 26.5 ± 4.9 kg/m2, p < 0.001), lower total GWG (6.2 ± 5.4 vs. 11.3 ± 5.8 kg, p < 0.001), but similar BMI-based excessive weight gain, higher fasting glucose (7.1 ± 2.4 vs. 5.1 ± 0.7 mmol/l) and HbA1c at GDM diagnosis (5.6 ± 1.0 vs. 5.3 ± 0.3%; both p ≤ 0.019), higher prevalence of previously undiagnosed pre-existing diabetes before 15-weeks gestational age (35.4% vs. 9.4%) and of metformin-treated women (84% vs. 1.1%, both p ≤ 0.001). The GC had higher well-being scores (74.4 ± 17.6 vs. 59.8 ± 18.3, p < 0.001), but similar symptoms of depression scores. In the GC, LGA (30% vs. 17%), and NICU hospitalizations (42% vs. 15%) were higher (all p ≤ 0.044) independent of HbA1c and pre-pregnancy BMI.

Conclusion

Women in the GC had worse metabolic outcomes but improved mental health during pregnancy. In this context, LGA and neonatal hospitalisations were higher, independent of HbA1c and pre-pregnancy BMI. Our results suggest the need for specialized GDM clinics in Ghana to improve metabolic and perinatal outcomes in women with GDM.